Adherence in Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Related Articles
Americans make many assumptions about aging, and health care providers are no exception.
COPD patients must clear major hurdles before and after initiating nebulizer use.
While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.
Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa).
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$